3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Breast Neoplasms
4
Ovarian Neoplasms
3
Triple Negative Breast Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Overweight
2
Obesity
2
Multiple Myeloma
2
Motor Activity
2
Melanoma
2
Lung Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Weight Loss
1
Uveal Melanoma
1
Smoking Cessation
1
Quality of Life
1
Postoperative Complications
1
Patient Compliance
1
Neoplasms
1
Metabolic Syndrome
1
Localized Prostate Carcinoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammation
1
Hypothalamic Neoplasms
1
Healthy Diet
1
Glioma
1
Gastrointestinal Neoplasms
1
Interventions
lutetium Lu 177 dotatate
20
Magnetic Resonance Spectroscopy
10
pembrolizumab
9
Specimen Handling
7
Everolimus
7
cabozantinib
6
Nivolumab
6
lenvatinib
5
177Lu-octreotide, DOTA(0)-Tyr(3)-
5
surufatinib
4
amino-acid, glucose, and electrolyte solution
4
Capecitabine
4
olaparib
3
lanreotide
3
atezolizumab
3
Temozolomide
3
Octreotide
3
Lutetium-177
3
Ipilimumab
3
Injections
3
Fluorodeoxyglucose F18
3
Cyclophosphamide
3
gallium Ga 68 dotatate
2
fludarabine phosphate
2
fludarabine
2
avelumab
2
X-Rays
2
Radiotherapy
2
Phantoms, Imaging
2
PM 01183
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Diet Therapy
×
1 year
×
Clear all
No trials found.